FGF19 Analog as a Surgical Factor Mimetic That Contributes to Metabolic Effects Beyond Glucose Homeostasis
Article Information
vol. 68 no. 6 1315-1328
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 11, 2018
- Accepted March 2, 2019
- Published in print May 20, 2019.
- Published online ahead of print March 12, 2019.
Article Versions
- Previous version (March 12, 2019 - 09:21).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2019 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
Author Information
- Alex M. DePaoli1,
- Mei Zhou1,
- Daniel D. Kaplan1,
- Steven C. Hunt2,3,
- Ted D. Adams2,4,
- R. Marc Learned1,
- Hui Tian1 and
- Lei Ling1⇑
- 1NGM Biopharmaceuticals, South San Francisco, CA
- 2Division of Cardiovascular Genetics, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT
- 3Department of Genetic Medicine, Weill Cornell Medicine, Doha, Qatar
- 4Intermountain LiveWell Center, Intermountain Healthcare, Salt Lake City, UT
- Corresponding author: Lei Ling, lling{at}ngmbio.com
Statistics from Altmetric.com
Article usage
In this Issue
June 2019, 68(6)
FGF19 Analog as a Surgical Factor Mimetic That Contributes to Metabolic Effects Beyond Glucose Homeostasis
